Atrophic Vaginitis: Irritation That Mimics Infection

What is atrophic vaginitis?

Atrophic vaginitis is inflammation and thinning of the vaginal walls caused by the drop in estrogen around and after menopause. As estrogen falls, the tissue becomes thinner, drier, less elastic, and more easily irritated. Clinicians now group these changes under the broader term genitourinary syndrome of menopause, which also affects the urethra and bladder 1Ref 1The North American Menopause Society (Menopause Society) (2020).The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.NAMS genitourinary syndrome of menopause statement: estrogen loss thins vaginal tissue, raises pH, and produces dryness, burning, and urinary symptoms, grouped as GSM..

Symptoms can include daily dryness, burning, itching, and discomfort with sex or wiping. Because natural menopause usually happens between 45 years and 55 years of age, most women who notice these changes are in midlife or beyond 2Ref 2World Health Organization (2024).Menopause (fact sheet).States that natural menopause typically occurs between ages 45 and 55, situating atrophic vaginitis in midlife and beyond.. Unlike a passing infection, atrophic vaginitis tends to persist and slowly worsen without treatment, which is one early clue that hormones — not microbes — are driving it.

How is it different from a yeast or bacterial infection?

The biggest difference is what is driving the symptoms: low estrogen versus an overgrowth of yeast or bacteria. A yeast infection often brings thick, white discharge and intense itching, while bacterial vaginosis tends to cause thin, gray discharge with a fishy odor.

Atrophic vaginitis, by contrast, usually produces little or no discharge — mostly dryness, rawness, and stinging. According to ACOG, vaginitis in women past menopause is frequently atrophic rather than infectious, so treating it as a yeast infection often fails 3Ref 3American College of Obstetricians and Gynecologists (2020).Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin, Number 215.ACOG guidance on vaginitis in nonpregnant patients, including that postmenopausal vaginitis is frequently atrophic rather than infectious and that confirming the diagnosis avoids ineffective treatment.. That mismatch is why many women use antifungal creams for 2 to 3 weeks before the real cause is found, and why symptoms that keep returning deserve an exam rather than another round of over-the-counter treatment.

Why does estrogen loss cause these symptoms?

Estrogen keeps vaginal tissue thick, moist, and slightly acidic, and its decline changes all three. Lower estrogen thins the surface layers, reduces natural lubrication, and raises vaginal pH, which shifts the balance of resident bacteria 1Ref 1The North American Menopause Society (Menopause Society) (2020).The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.NAMS genitourinary syndrome of menopause statement: estrogen loss thins vaginal tissue, raises pH, and produces dryness, burning, and urinary symptoms, grouped as GSM.. The same hormone shift can make the urethra more sensitive and contribute to urinary urgency or repeat urinary infections, which is why some women notice bladder symptoms alongside dryness.

These changes can begin during perimenopause, sometimes 4 to 5 years before periods fully stop, and they typically progress rather than resolve on their own 2Ref 2World Health Organization (2024).Menopause (fact sheet).States that natural menopause typically occurs between ages 45 and 55, situating atrophic vaginitis in midlife and beyond.. Unlike hot flashes, which often fade with time, genitourinary symptoms usually persist, so they are worth naming to a clinician even when other menopause symptoms have settled.

What actually helps atrophic vaginitis?

Restoring estrogen locally is the most effective approach for moderate to severe symptoms. A Cochrane review found low-dose vaginal estrogen improves dryness and irritation in postmenopausal women, with very little hormone absorbed 4Ref 4Lethaby A, Ayeleke RO, Roberts H (2016).Local oestrogen for vaginal atrophy in postmenopausal women.Cochrane review finding that low-dose local vaginal estrogen improves atrophic vaginal symptoms in postmenopausal women with minimal systemic absorption..

Options that clinicians may discuss include:

• Vaginal moisturizers, used regularly (often every 2 to 3 days), and lubricants for sex, which can ease mild symptoms without hormones
• Low-dose vaginal estrogen creams, tablets, or rings, which directly rebuild the tissue 4Ref 4Lethaby A, Ayeleke RO, Roberts H (2016).Local oestrogen for vaginal atrophy in postmenopausal women.Cochrane review finding that low-dose local vaginal estrogen improves atrophic vaginal symptoms in postmenopausal women with minimal systemic absorption.
• Other prescription options, such as vaginal DHEA or oral ospemifene, for women who prefer not to use estrogen

According to the North American Menopause Society, vaginal estrogen is considered safe for most women, including many with a history of breast cancer after specialist discussion 5Ref 5American College of Obstetricians and Gynecologists (2016).The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer.ACOG committee opinion supporting vaginal estrogen for genitourinary symptoms, including in many women with a history of estrogen-dependent breast cancer after individualized discussion.. The best fit among these vaginal dryness options depends on symptom severity and personal history.

When atrophic vaginitis needs a clinician

A clinician visit makes sense when dryness and irritation persist, worsen, or do not respond to over-the-counter products. An exam can distinguish atrophic vaginitis from infection, and sometimes from skin conditions that need different care.

New bleeding, a lump, a sore that does not heal, or foul-smelling discharge always deserve evaluation rather than self-treatment. Because symptoms that mimic infection can lead to months of ineffective antifungal use, naming them precisely matters. According to ACOG, confirming the diagnosis before treatment avoids unnecessary medication and speeds relief 3Ref 3American College of Obstetricians and Gynecologists (2020).Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin, Number 215.ACOG guidance on vaginitis in nonpregnant patients, including that postmenopausal vaginitis is frequently atrophic rather than infectious and that confirming the diagnosis avoids ineffective treatment.. Gale can help you organize your symptoms and questions before that visit, so the conversation focuses on what is actually causing the irritation.